CN101367885A - 一种苹果酸壳寡糖复合盐及其制备方法和应用 - Google Patents
一种苹果酸壳寡糖复合盐及其制备方法和应用 Download PDFInfo
- Publication number
- CN101367885A CN101367885A CNA2008102236827A CN200810223682A CN101367885A CN 101367885 A CN101367885 A CN 101367885A CN A2008102236827 A CNA2008102236827 A CN A2008102236827A CN 200810223682 A CN200810223682 A CN 200810223682A CN 101367885 A CN101367885 A CN 101367885A
- Authority
- CN
- China
- Prior art keywords
- malic acid
- oligosaccharide compound
- compound salt
- chitosan oligosaccharide
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 235000011090 malic acid Nutrition 0.000 title claims abstract description 49
- -1 Malic acid chitosan oligosaccharide compound salt Chemical class 0.000 title claims abstract description 47
- 239000001630 malic acid Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229920001661 Chitosan Polymers 0.000 claims abstract description 53
- 229940099690 malic acid Drugs 0.000 claims abstract description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- 150000003839 salts Chemical class 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940116298 l- malic acid Drugs 0.000 claims abstract description 12
- 238000001291 vacuum drying Methods 0.000 claims abstract description 9
- 238000005406 washing Methods 0.000 claims abstract description 8
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 239000013538 functional additive Substances 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 238000001816 cooling Methods 0.000 claims abstract description 3
- 239000002253 acid Substances 0.000 claims description 54
- 239000002131 composite material Substances 0.000 claims description 29
- 230000007062 hydrolysis Effects 0.000 claims description 23
- 238000006460 hydrolysis reaction Methods 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 14
- 238000004458 analytical method Methods 0.000 claims description 11
- 238000003381 deacetylation reaction Methods 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 230000006196 deacetylation Effects 0.000 claims description 8
- 241000920701 Batillus Species 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 239000002778 food additive Substances 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 108010093096 Immobilized Enzymes Proteins 0.000 claims description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 2
- 238000013019 agitation Methods 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract description 9
- 102000004190 Enzymes Human genes 0.000 abstract description 8
- 108090000790 Enzymes Proteins 0.000 abstract description 8
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 108010089807 chitosanase Proteins 0.000 abstract 2
- 238000002156 mixing Methods 0.000 abstract 2
- 230000000850 deacetylating effect Effects 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000004064 recycling Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 15
- 239000012153 distilled water Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000370738 Chlorion Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000554541 Crangon crangon Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- UDLOAJGWSDUKME-LURJTMIESA-N alpha-Butoxy-succinic-acid Natural products CCCCO[C@@H](CC(O)=O)C(O)=O UDLOAJGWSDUKME-LURJTMIESA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000002302 glucosamines Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
Images
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102236827A CN101367885B (zh) | 2008-10-07 | 2008-10-07 | 一种苹果酸壳寡糖复合盐及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102236827A CN101367885B (zh) | 2008-10-07 | 2008-10-07 | 一种苹果酸壳寡糖复合盐及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101367885A true CN101367885A (zh) | 2009-02-18 |
CN101367885B CN101367885B (zh) | 2010-12-01 |
Family
ID=40411896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102236827A Active CN101367885B (zh) | 2008-10-07 | 2008-10-07 | 一种苹果酸壳寡糖复合盐及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101367885B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107216409A (zh) * | 2015-08-27 | 2017-09-29 | 武汉轻工大学 | 一种壳聚糖‑l‑苹果酸‑稀土配合物的制备方法 |
CN107880272A (zh) * | 2017-11-27 | 2018-04-06 | 安徽雪郎生物科技股份有限公司 | 一种β‑聚苹果酸壳寡糖复合盐及其制备方法和应用 |
CN112626147A (zh) * | 2021-01-12 | 2021-04-09 | 中国科学院海洋研究所 | 一种壳寡糖盐的制备方法 |
-
2008
- 2008-10-07 CN CN2008102236827A patent/CN101367885B/zh active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107216409A (zh) * | 2015-08-27 | 2017-09-29 | 武汉轻工大学 | 一种壳聚糖‑l‑苹果酸‑稀土配合物的制备方法 |
CN107880272A (zh) * | 2017-11-27 | 2018-04-06 | 安徽雪郎生物科技股份有限公司 | 一种β‑聚苹果酸壳寡糖复合盐及其制备方法和应用 |
CN107880272B (zh) * | 2017-11-27 | 2020-06-05 | 安徽雪郎生物科技股份有限公司 | 一种β-聚苹果酸壳寡糖复合盐及其制备方法和应用 |
CN112626147A (zh) * | 2021-01-12 | 2021-04-09 | 中国科学院海洋研究所 | 一种壳寡糖盐的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101367885B (zh) | 2010-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qiang et al. | Health benefit application of functional oligosaccharides | |
KR100674672B1 (ko) | 키토산 함유 다당, 그 제조방법 및 용도 | |
TWI235660B (en) | Drugs against articular failure | |
EP2387332A2 (en) | A process for the production of a composition, the composition and the use thereof as food additive | |
CN101367885B (zh) | 一种苹果酸壳寡糖复合盐及其制备方法和应用 | |
CN1908019A (zh) | 壳寡糖硫酸盐及其制备方法 | |
CN110128489A (zh) | 一种自水解制备半乳甘露低聚糖的方法 | |
CN101570554B (zh) | 一种补锌剂羧甲基壳寡糖锌的制备方法 | |
JPH0987302A (ja) | キトサンを含む組成物 | |
CN101912407B (zh) | 一种减肥降脂组合物 | |
DK2865278T3 (en) | Binder fat obtained from biomass, derived from beer production | |
US20060240168A1 (en) | Chitosan foodstuff | |
JP3884611B2 (ja) | 衝動性疾患の改善剤 | |
JP2003048839A (ja) | 免疫反応性NO合成を誘導するiNOS酵素を刺激する組成剤およびその製造方法 | |
JP5564205B2 (ja) | 皮膚掻痒症改善剤 | |
JP2005263688A (ja) | α−グルコシダーゼ阻害剤 | |
CN112042798A (zh) | 一种增强儿童免疫力的凝胶糖果及其制备方法 | |
JP2002275073A (ja) | 血圧上昇抑制性組成物 | |
CN106279306A (zh) | 一种o-酰基化卡拉胶寡糖螯合钙及其制备方法 | |
CN104207142B (zh) | 一种补锌与排毒营养保健剂的制备方法 | |
CN1250093C (zh) | 活性钙胡萝卜素系列饼干及其制造方法 | |
US20140220080A1 (en) | IgA SECRETION PROMOTER | |
KR100242747B1 (ko) | 떫은 맛이 적고 아미노기의 잔류량이 많은 저분자형 키토산 용액의 제조방법 | |
CN111955726A (zh) | 一种减脂塑身通便润肠的食品组合物生产方法及组合物 | |
CN102090562A (zh) | 减肥型木糖醇 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20090218 Assignee: Nanjing Kokhai Biotechnical Co., Ltd. Assignor: Li Yunzheng Contract record no.: 2010320000437 Denomination of invention: Malic acid chitosan oligosaccharide compound salt, preparation and uses thereof License type: Exclusive License Record date: 20100422 |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Nanjing Kokhai Biotechnical Co., Ltd. Assignor: Li Yunzheng Contract record no.: 2010320000437 Date of cancellation: 20120316 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Anhui Sealong Biotechnology Co., Ltd. Assignor: Li Yunzheng Contract record no.: 2012340000101 Denomination of invention: Malic acid chitosan oligosaccharide compound salt, preparation and uses thereof Granted publication date: 20101201 License type: Exclusive License Open date: 20090218 Record date: 20120406 |
|
ASS | Succession or assignment of patent right |
Owner name: ANHUI SEALONG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LI YUNZHENG Effective date: 20130619 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100096 HAIDIAN, BEIJING TO: 233000 BENGBU, ANHUI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130619 Address after: Hekou Economic Development Zone Industrial Park in Anhui city of Bengbu province Wuhe County 233000 Mo Chonglu No. 6 gold Patentee after: Anhui Sealong Biotechnology Co., Ltd. Address before: 100096 Beijing city Haidian District new garden 36 Building No. 2, producing up to 402 Patentee before: Li Yunzheng |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Malic acid chitosan oligosaccharide compound salt, preparation and uses thereof Effective date of registration: 20191223 Granted publication date: 20101201 Pledgee: Bengbu financing guarantee Group Co., Ltd. Pledgor: Anhui Sealong Biotechnology Co., Ltd. Registration number: Y2019980001230 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220317 Granted publication date: 20101201 Pledgee: Bengbu financing guarantee Group Co.,Ltd. Pledgor: ANHUI SEALONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2019980001230 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |